Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04269096 · ClinicalTrials.gov registry record
Laparoscopic Cholecystectomy Care Protocol
A clinical trial of Laparoscopic Cholecystectomy, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04269096: Completed study of Laparoscopic Cholecystectomy, sponsored by Prisma Health-Upstate.
NCT04269096 is a study of Laparoscopic Cholecystectomy that has completed, run by Prisma Health-Upstate. The registered enrollment target is 500 participants, above the 195-participant average among 4 other Laparoscopic Cholecystectomy trials with a reported enrollment target (156% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04269096, a study of Laparoscopic Cholecystectomy, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine compliance with the Prisma Health-Upstate Laparoscopic Cholecystectomy Perioperative Protocol.
Primary Outcome
Percent compliance with protocol components
Conditions Studied
Interventions
- OTHER Protocol Compliance
Study Locations (1)
South Carolina
- Greenville Memorial Hospital - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2021-04-01 |
What the finished NCT04269096 record still lists
NCT04269096 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 195-participant average among 4 other Laparoscopic Cholecystectomy trials with a reported enrollment target (156% higher).
The record links to 1 condition, with Laparoscopic Cholecystectomy appearing as the primary indexed condition, and to 1 intervention - of which Protocol Compliance is the first listed.
NCT04269096 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT04269096 about?
NCT04269096 is a clinical study titled "Laparoscopic Cholecystectomy Care Protocol". The purpose of this study is to determine compliance with the Prisma Health-Upstate Laparoscopic Cholecystectomy Perioperative Protocol.
What is the current status of trial NCT04269096?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2016-01-01. Estimated completion is 2021-04-01.
What conditions does trial NCT04269096 study?
This clinical trial studies the following conditions: Laparoscopic Cholecystectomy.
What interventions are being tested in trial NCT04269096?
The interventions under investigation include: Protocol Compliance (OTHER).
Who is sponsoring clinical trial NCT04269096?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04269096 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laparoscopic Cholecystectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
RECRUITING · NA
-
Nerve Blocks vs Local Injections for Post-op Pain Prevention in Laparoscopic Cholecystectomy in Children
COMPLETED · NA
-
A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain
COMPLETED · Phase 3
-
Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI